Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of oral sodium tungstate 200 mg/day on weight loss in male patients with grade I–II obesity
2006-000567-28Phase 2Active
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity comparing Sodium tungstate with Placebo (2 arms). Primary endpoints: Absolute change in body weight and Proportion of patients with clinically significant weight loss. Started Aug 2007; status: active.
02
Drugs
sodium tungstate
03
Conditions
obesity
Beyond the preview
Go deeper on 2006-000567-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000567-28.